BioCentury
ARTICLE | Company News

Cadus Pharmaceutical Corp. deal

February 24, 2003 8:00 AM UTC

Cadus Technologies Inc., a subsidiary of KDUS, received a $1 million milestone from an undisclosed pharmaceutical company as part of a 2001 non-exclusive licensing deal for access to Cadus' yeast-base...